References
1. Thomas, E.D., et al., Current status of bone marrow transplantation for aplastic anemia and acute leukemia. Blood, 1977.49 (5): p. 671-81.
2. Appelbaum, F.R., The use of bone marrow and peripheral blood stem cell transplantation in the treatment of cancer. CA Cancer J Clin, 1996. 46 (3): p. 142-64.
3. Appelbaum, F.R., et al., Study of cell dose and storage time on engraftment of cryopreserved autologous bone marrow in a canine model.Transplantation, 1978. 26 (4): p. 245-8.
4. Shibuya, T.Y., et al., Sinus disease in the bone marrow transplant population: incidence, risk factors, and complications.Otolaryngol Head Neck Surg, 1995. 113 (6): p. 705-11.
5. Ganzel, T.M., et al., Otolaryngologic problems in cardiac transplant patients. Laryngoscope, 1989. 99 (2): p. 158-61.
6. Hizal, E., et al., Otorhinolaryngologic Problems in Liver and Kidney Transplant Recipients. Exp Clin Transplant, 2018.
7. Narazaki, T., et al., Schizophyllum commune sinusitis after allogeneic bone marrow transplantation for myelodysplastic syndrome: A case report and literature review. Transpl Infect Dis, 2020.22 (1): p. e13205.
8. Eliashar, R., et al., Endoscopic surgery for sinonasal invasive aspergillosis in bone marrow transplantation patients. Laryngoscope, 2007. 117 (1): p. 78-81.
9. Pandrangi, V. and E.R. Reiter, The Burden of Sinusitis in Hematologic Transplant Patients: A National Perspective. Laryngoscope, 2018. 128 (12): p. 2688-2692.
10. Fischer, M., et al., The value of ablating oto-rhino-laryngological (ORL) foci before haematopoietic stem cell transplantation (HSCT). Ann Hematol, 2002. 81 (4): p. 198-201.
11. Pollard, R.B., et al., Specific cell-mediated immunity and infections with herpes viruses in cardiac transplant recipients. Am J Med, 1982. 73 (5): p. 679-87.
12. Preiksaitis, J.K., et al., Infections due to herpesviruses in cardiac transplant recipients: role of the donor heart and immunosuppressive therapy. J Infect Dis, 1983. 147 (6): p. 974-81.
13. Chou, S., J.G. Gallagher, and T.C. Merigan, Controlled clinical trial of intravenous acyclovir in heart-transplant patients with mucocutaneous herpes simplex infections. Lancet, 1981.1 (8235): p. 1392-4.
14. Haverman, T.M., et al., Oral complications in hematopoietic stem cell recipients: the role of inflammation. Mediators Inflamm, 2014. 2014 : p. 378281.